γδ T Cell Therapy for Relapse Prevention in High-Risk AML Post-Transplant
Clinical trial NCT07123662 · WITHDRAWN
Trial details
- NCT number
- NCT07123662
- Sponsor
- Guangzhou Bio-gene Technology Co., Ltd
- Status
- WITHDRAWN
- Phase
- Early Phase 1
- Study type
- INTERVENTIONAL
- Start date
- 2025-09-01
- Primary completion
- 2028-05-30
- Enrollment
- 0
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.